A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
2,3-Dinor 11 Beta-Prostaglandin F2 Alpha, Random, Urine
Test Code23BPG
Quest Code
10041
Includes
Creatinine
Preferred Specimen
5 mL random urine collected in a plastic 5 mL tube
Patient Preparation
Patients taking aspirin or nonsteroidal anti-inflammatory drugs (NSAID) may have decreased concentrations of prostaglandin F2 alpha. If possible, discontinue for 2 weeks or 72 hours, respectively, prior to collecting a specimen.
Minimum Volume
4 mL
Transport Container
Plastic 5 mL tube
Transport Temperature
Frozen
Specimen Stability
Room temperature: 8 hours
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Methodology
Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS) • Enzymatic Colorimetric Assay
FDA Status
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.
Reference Range
See Laboratory Report
Clinical Significance
Screening for mast cell activation disorders including systemic mastocytosis using random urine specimens.
Performing Laboratory
Mayo Clinical Laboratories |
200 1st Street SW |
Rochester, MN 55905-0001 |